The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Regulation of E-cadherin Expression by VHL and Hypoxia-Inducible Factor
Open accessAbstract
Mutations in von Hippel-Lindau tumor suppressor gene (VHL) underlie the VHL hereditary cancer syndrome and also occur in most sporadic clear cell renal cell cancers (CCRCC). Currently, the mechanism(s) by which VHL loss of function promotes tumor development in the kidney are not fully elucidated. Here, we show that VHL inactivation in precancerous lesions in kidneys from patients with VHL disease correlates with marked down-regulation of the intercellular adhesion molecule E-cadherin. Moreover, in VHL-defective cell lines (RCC4 and RCC10) derived from sporadic CCRCC, reexpression of VHL was found to restore E-cadherin expression. The product of the VHL gene has multiple reported functions, the best characterized of which is its role as the recognition component of an ubiquitin E3 ligase complex responsible for mediating oxygen-dependent destruction of hypoxia-inducible factor-α (HIF-α) subunits. We show that HIF activation is necessary and sufficient to suppress E-cadherin in renal cancer cells. Given the fundamental role of E-cadherin in controlling epithelial behavior, our findings give insight into how VHL inactivation/HIF activation may lead to kidney cancer and also indicate a mechanism by which reduced oxygenation could alter E-cadherin expression in other cancers and influence normal homeostasis in other epithelia. (Cancer Res 2006; 66(7): 3567-75)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Loss of VHL in ccRCC also downregulates E-cadherin in a HIF-dependent manner (Esteban et al., 2006).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Esteban et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationCano, A., Pérez‐Moreno, M., Rodrigo, I., Locascio, A., Blanco, M. J., Barrio, M. G. D., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,672
Batlle, E., Sancho, E., Francí, C., Dominguez-Sola, D., Monfar, M., Baulida, J., & de Herreros, A. G. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,730
Multifunctional strands in tight junctions
Tsukita, S., Furuse, M., & Itoh, M. (2001) · Nature reviews. Molecular cell biology · doi:10.1038/35067088 · Cited by 2,578
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
The snail superfamily of zinc-finger transcription factors
Nieto, M. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm757 · Cited by 1,719
A causal role for E-cadherin in the transition from adenoma to carcinoma
Perl, A. T., Wilgenbus, P., Dahl, U., Semb, H., & Christofori, G. (1998) · Nature · doi:10.1038/32433 · Cited by 1,419
Cited by
Sorted by citations
Items 201–263 of 263
Targeting HIF-1α in sickle cell disease and cancer: unraveling therapeutic opportunities and risks
Ubaid, S., Kashif, M., Laiq, Y., Nayak, A., Kumar, V., & Singh, V. K. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2367640 · Cited by 13
Zhao, J., Zhang, H., Liu, Y., Lu, G., Wang, Z., Mo, Q., Wang, G., Shen, Y., & Jiao, L.-Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37900 · Cited by 11
Hereditary Diffuse Gastric Cancer and Lost Cell Polarity: A Short Path To Cancer
Humar, B., & Guilford, P. (2008) · Future Oncology · doi:10.2217/14796694.4.2.229 · Cited by 12
Müssig, E., Steinberg, T., Kohl, A., Chamulitrat, W., Komposch, G., & Tomakidi, P. (2008) · Cell and Tissue Research · doi:10.1007/s00441-007-0551-y · Cited by 11
Yi, H., Han, Y., Li, Q., Lin, R., Zhang, J., Yang, Y., Wang, X., & Zhang, L. (2023) · Oncology Letters · doi:10.3892/ol.2023.13990 · Cited by 10
4.1N-Mediated Interactions and Functions in Nerve System and Cancer
Yang, Q., Liu, J., & Wang, Z. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.711302 · Cited by 10
Mangiavini, L., Merceron, C., Araldi, E., Khatri, R., Gerard-O’Riley, R. L., Wilson, T. L., Sandusky, G. E., Abadie, J., Lyons, K. M., Giaccia, A. J., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.07.008 · Cited by 11
LI, H.-C., Li, J., Wang, Z., Fu, D., Li, Z., ZHANG, D., Gan, W., & Chong, T. (2014) · Oncology Reports · doi:10.3892/or.2014.3403 · Cited by 10
Alterations in Stromal Reaction During Tumor Progression in Oral Mucosa
Yokoyama, M. (2011) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.20.23 · Cited by 10
Catalano, A., Haas, L. S., Zodel, K., Adlesic, M., Cuomo, F., Peighambari, A., Metzger, P., Huang, H., Haug, S., Köttgen, A., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.12.003 · Cited by 9
Biological characteristics of prostate cancer cells are regulated by hypoxia-inducible factor 1α
Huang, X., Zhou, J., LIU, J., Tang, B., Zhao, F., & Qu, Y. (2014) · Oncology Letters · doi:10.3892/ol.2014.2259 · Cited by 9
Loss of PL6 protein expression in renal clear cell carcinomas and other VHL‐deficient tumours
Иванова, А. В., Vortmeyer, A. O., Ivanov, S. V., Nickerson, M. L., Maher, E. R., & Lerman, M. I. (2007) · The Journal of Pathology · doi:10.1002/path.2252 · Cited by 9
Shenoy, N. K., Shrivastava, M. S., Sukrithan, V., Papaspyridi, D., & Darbinyan, K. (2015) · Journal of Cancer Therapy · doi:10.4236/jct.2015.66055 · Cited by 7
Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma
Akuma, M., Kim, M., Zhu, C., Wiljer, E., Gaudreau-Lapierre, A., Patterson, L. D., Egevad, L., Tanguay, S., Trinkle‐Mulcahy, L., Stanford, W. L., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07623-y · Cited by 10
Kious, K. W., Savage, K., Twohey, S. C. E., Highum, A. F., Philipose, A., Díaz, H. S., Río, R. D., Lang, J. A., Clayton, S., & Marcus, N. J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1235289 · Cited by 7
S iah2‐deficient mice show impaired skin wound repair
Musyoka, J. N., Liu, M. C. P., Pouniotis, D. S., Wong, C. S. F., Bowtell, D. D. L., Little, P. J., Getachew, R., Möller, A., & Darby, I. A. (2013) · Wound Repair and Regeneration · doi:10.1111/wrr.12045 · Cited by 7
Genetic insights into the hypoxia-inducible factor (HIF) pathway
Kiriakidis, S., Esteban, M. A., & Maxwell, P. H. (2007) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.12.009 · Cited by 6
Self-citation4.1N suppresses hypoxia-induced epithelial-mesenchymal transition in epithelial ovarian cancer cells
Zhang, L., Hu, A., Li, M., Zhang, H., Ren, C., An, X., & Liu, C. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4634 · Cited by 6
Jensen, C. C., & Warfel, N. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00039-6 · Cited by 5
Subcellular Dynamics of The VHL Tumor Suppressor: On The Move for HIF Degradation
Khacho, M., & Lee, S. (2009) · Future Oncology · doi:10.2217/14796694.5.1.85 · Cited by 4
Kious, K. W., Philipose, A., Smith, L. J., Kemble, J. P., Twohey, S. C. E., Savage, K., Díaz, H. S., Río, R. D., & Marcus, N. J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.955538 · Cited by 4
Li, S.-C., Yan, L., Wei, X.-L., Jia, Z.-K., Yang, J., & Ning, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1038457 · Cited by 3
Raykhel, I. B., Ronkainen, V., Myllyharju, J., & Manninen, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-62955-7 · Cited by 3
Inflammation and Lung Cancer: The Role of Epithelial–Mesenchymal Transition
Walser, T. C., Park, S. J., Yanagawa, J., & Dubinett, S. M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2724-1_2 · Cited by 4
Molecular Pathology of the Genitourinary Tract: Molecular Pathology of Kidney and Testes
Sirintrapun, S. J., & Parwani, A. V. (2009) · Surgical pathology clinics · doi:10.1016/j.path.2008.08.003 · Cited by 3
The VHL-HIF Signaling in Renal Cell Carcinoma: Promises and Pitfalls
Morais, C., David, W., & Glenda, C. (2012) · InTech eBooks · doi:10.5772/27009 · Cited by 3
Schoenfeld, A. R. (2012) · Cell & Developmental Biology · doi:10.4172/2168-9296.1000118 · Cited by 3
Chesnel, F., Jullion, E., Delalande, O., Couturier, A., Alusse, A., Goff, X. L., Lenglet, M., Gardie, B., Abadie, C., & Arlot‐Bonnemains, Y. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01985-2 · Cited by 3
Von Hippel-Lindau protein and respiratory diseases
Chen, T. (2013) · World Journal of Respirology · doi:10.5320/wjr.v3.i3.48 · Cited by 3
Park, H. (2008) · Toxicological Research · doi:10.5487/tr.2008.24.2.101 · Cited by 2
Characterization Of A Non-Canonical Function For Threonyl-Trna Synthetase In Angiogenesis
Mirando, A. C. (2015) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont) · Cited by 2
Early Metastasis in Colorectal Cancer Poses an Option for New Diagnostic and Treatment Strategies
Adwan, H., ElHarouni, D., Habashy, D. A., Banna, N., Georges, R. B., Pervaiz, A., & Berger, M. R. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.79637 · Cited by 2
Grubb, T. M., Maganti, S., Krill-Burger, J. M., Fraser, C. S., Stransky, L. A., Radivoyevitch, T., Sarosiek, K. A., Vázquez, F., Kaelin, W. G., & Chakraborty, A. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.29.478337 · Cited by 2
Zhang, M., Zhang, Y., Shen, F., Yan, M., Cheng, P., Teng, J., Zou, M., Yao, W., Wang, Z., & Li, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1761280 · Cited by 1
THE VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN AND KIDNEY CANCER
Kaelin, W. G., & Ma, B. (2007) · Medicina-buenos Aires · Cited by 1
Molecular identification and characterization of pig's Cdh16 gene
Ye, J., He, J. H., & Li, N. (2018) · Gene Reports · doi:10.1016/j.genrep.2018.11.001 · Cited by 1
Hypoxia in Drug Resistance and Radioresistance
Chang, K., Lin, I., & Cheung, C. H. A. (2023) · Springer eBooks · doi:10.1007/978-981-99-0313-9_19 · Cited by 1
HIF-опосредованные механизмы взаимосвязи устойчивости к гипоксии и опухолевого роста
Dzhalilova, D. S., & Makarova, O. V. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521100018 · Cited by 1
Hypoxia-induced metastasis : the role of the unfolded protein response
Mujčić, H. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20130912hm · Cited by 1
Brassard-Jollive, N., Atlas, Y., Compere, C. L., Ardidie‐Robouant, C., Mailly, P., Bouchtaoui, M. E., Lelarge, V., Blot, G., Josseaume, N., Oliveira, S. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.27.645644 · Cited by 1
von Fintel, H. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1051
Hypoxia Mediated Signaling Pathways
Chan, D. A., Koong, A. C., & Giaccia, A. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00269-2
[Molecular biology of renal cancer: bases for genetic directed therapy in advanced disease].
Maroto, P., & Narvaez, E. C. (2013) · PubMed
Dayoub, R. (2010) · University of Regensburg Publication Server (University of Regensburg)
Implications of Cancer Stem Cells for Tumor Metastasis
Kalani, M. A., Dalerba, P. D., & Clarke, M. F. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-087-8_38
Transcriptional Regulation by Hypoxia-Inducible Factors in Tumor Cells
Löfstedt, T. (2007) · Lund University Publications (Lund University)
Rohwer, N. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-16153
Protein-protein interactions mediating hypoxia-inducible factor 1 complex function
Jagdeo, J. M. (2012) · Summit (Simon Fraser University)
Gossage, L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1622-1_4
Biología molecular de los tumores corticales renales
Klatte, T., & Pantuck, A. J. (2008) · Clínicas urológicas de Norteamérica
Metabolism and Motility: Characterizing Metabolic Changes that Lead to Metastasis.
Wassenhove, V., & Wassenhove, L. D. V. (2013)
The Cellular Oxygen Sensor PHD2 in Cancer Growth
Jokilehto, T. (2011) · UTUPub (University of Turku)
The Molecular Genetics and Pathology of Renal Cell Carcinoma
Tran, M. G. B., O’Brien, T., & Maxwell, P. H. (2010) · CRC Press eBooks · doi:10.3109/9781841847498-24
Self-citationMechanisms of Colorectal Cancer Pathogenesis: Role of Hypoxia
Thairu, N. (2013) · doi:10.25560/14361
Role of Hypoxia-inducible Factor in Kidney Cancer
Roberts, A. M. (2012) · TSpace (University of Toronto)
Impact of hypoxia on hepatitis B virus replication
Frampton, N. R. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham)
Genetic instability upon the loss of the tumour suppressor folliculin (FLCN)
Russell, R.-A. (2019) · ORCA Online Research @Cardiff (Cardiff University)
Hypoxia and Metastatic Disease
Todd, V. M., & Johnson, R. W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11243-7
Hypoxia-Inducible Factors: Regulation and Therapeutic Potential
Lin, I., Chang, K., Cheng, F., Kanwar, R. K., Kamplikar, P., Kanwar, J. R., & Cheung, C. H. A. (2025) · Springer eBooks · doi:10.1007/978-981-96-1016-7_11
Influence of hypoxia on tumour cell susceptibility to cytotoxic T lymphocyte mediated lysis
Noman, M. Z. (2012) · theses.fr (ABES) · doi:10.70675/306da2eez5bc3z478ez83c5zdc39407a896e
Role of VDAC1 hypoxic form, VDAC1-∆C, in the expression of primary cilia and tumor progression
Fabbri, L. (2019) · theses.fr (ABES) · doi:10.70675/7a53239dzc652z4ea4z8b95z4a71961c83b4
Investigating the role of the centromeric histone variant CENP-A in cancer
Renaud-Pageot, C. (2024) · theses.fr (ABES) · doi:10.70675/eb41b5bfz0c52z4889z9d8czf04f426b8666
Brassard-Jollive, N., Atlas, Y., Compere, C. L., Ardidie‐Robouant, C., Mailly, P., Bouchtaoui, M. E., Lelarge, V., Blot, G., Josseaume, N., de Oliveira, S., et al. (2026) · Angiogenesis · doi:10.1007/s10456-026-10073-5 · Cited by 1
Metadata
- Authors
- Esteban, M. A., Tran, M. G. B., Harten, S. K., Hill, P., Castellanos, M. C., Chandra, A., Raval, R., O'Brien, T. S., & Maxwell, P. H.
- Affiliations
- Imperial College London (GB)
- 3Servicio de Immunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain; and
- Guy's Hospital (GB)
- 4Henry Wellcome Building of Genomic Medicine, Oxford, United Kingdom
- 2Department of Urology, Guy's Hospital, London Bridge, London, United Kingdom;
- Venue
- Cancer Research
- Published
- 2006-04-01
- Volume
- 66
- Issue
- 7
- Pages
- 3567-3575
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2039412091
- Cited by
- 262
- References
- 37
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 10 · 2017: 5 · 2016: 14 · 2015: 14 · 2014: 18 · 2013: 17 · 2012: 19
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust
- European Commission
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- E-cadherin, von Hippel-Lindau tumor suppressor, hypoxia-inducible factor alpha, clear cell renal cell carcinoma, von Hippel-Lindau disease, cell-cell adhesion, epithelial cell adhesion, E3 ubiquitin ligase, tumor suppressor inactivation, oxygenation
- MeSH terms
- Adult, Carcinoma, Renal Cell, Cell Transformation, Neoplastic, Female, von Hippel-Lindau Disease, Humans, Kidney Neoplasms, Kidney Tubules, Male, Middle Aged, Precancerous Conditions, RNA, Messenger, Down-Regulation, Cadherins, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
